Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Lane

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patientsR A Lempicki, J A Kovacs, M W Baseler, et al.
Clinical Immunology (Orlando, Fla.)|April 19, 2015
Tuberculosis specific responses following therapy for TB: Impact of HIV co-infectionS Siddiqui, Y Sarro, B Diarra, et al.
JAMA|July 13, 2000
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trialR T Davey, R L Murphy, F M Graziano, et al.
Nature Medicine|July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adultsR E Walker, C S Carter, L Muul, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
JAMA|November 30, 1999
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisS M Whitcup, E Fortin, A S Lindblad, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionR T Davey, N Bhat, C Yoder, et al.
The Journal of Experimental Medicine|December 19, 2001
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIVJ A Kovacs, R A Lempicki, I A Sidorov, et al.
Blood|July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infectionR E Walker, C M Bechtel, V Natarajan, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patientsR A Lempicki, J A Kovacs, M W Baseler, et al.
Clinical Immunology (Orlando, Fla.)|April 19, 2015
Tuberculosis specific responses following therapy for TB: Impact of HIV co-infectionS Siddiqui, Y Sarro, B Diarra, et al.
JAMA|July 13, 2000
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trialR T Davey, R L Murphy, F M Graziano, et al.
Nature Medicine|July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adultsR E Walker, C S Carter, L Muul, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
JAMA|November 30, 1999
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisS M Whitcup, E Fortin, A S Lindblad, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionR T Davey, N Bhat, C Yoder, et al.
The Journal of Experimental Medicine|December 19, 2001
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIVJ A Kovacs, R A Lempicki, I A Sidorov, et al.
Blood|July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infectionR E Walker, C M Bechtel, V Natarajan, et al.
Pageof 21